drugset / Trial / NCT02660242

The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

NCT02660242

RandomizedCrossoverSingle-blindPrevention

Summary

This project focuses on development of new strategy for the prevention of exercise-associated hypoglycemia using mini-dose glucagon.

Timeline

Start
2016-01
Primary completion
2017-02-15
Completion
2017-02-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucagon Peptide 150 ug Subcutaneous